Intact Therapeutics
Smart gels for local drug delivery to the gut
Palo Alto, United States · Founded 2015 · $1.5M raised
- Headquarters
- Palo Alto, California
- Employees
- 1–10
- Founded
- 2015
- Website
- intacttherapeutics.com
- Total Funding
- $1.5M
- Last Round
- GrantJan 2015
- Rounds
- 1
About
Intatct is developing an advanced materials platform to improve the way drugs are delivered and absorbed in the digestive tract. Our vision is to improve the treatment of a wide range of gastrointestinal disorders that are currently underserved.
Summary
Intact Therapeutics is a Drug Discovery company based in Palo Alto, United States, founded in 2015. It has raised $1.5M in total across 1 round, most recently a Grant round in Jan 2015. Investors include VentureWell.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2015
Investors
Similar Companies
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...